DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Brose MS, Nutting CM, Jarzab B. et al.
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic
differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Lancet 2014;
384: 319-328
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.